Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04707885 · ClinicalTrials.gov registry record · NA

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

A NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
5
Study locations

NCT04707885 is a NA study of Hearing Loss and Hearing Loss, Sensorineural that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 40 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04707885, a NA study of Hearing Loss and Hearing Loss, Sensorineural, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
5
Study locations

Study Summary

The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).

Interventions

  • DEVICE Electrocochleography

Study Locations (5)

Minnesota

  • Mayo Clinic - Rochester

Missouri

  • Washington University in St. Louis - St Louis

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill

Ohio

  • Ohio State University Eye and Ear Institute - Columbus

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-11-10
Est. Completion 2027-12-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT04707885

The ClinicalTrials.gov registry entry for NCT04707885 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Electrocochleography is the first listed.

NCT04707885 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Minnesota, Missouri, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04707885 about?

NCT04707885 is a clinical study titled "Clinical Utility of Residual Hearing in the Cochlear Implant Ear". The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).

What is the current status of trial NCT04707885?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-11-10. Estimated completion is 2027-12-31.

What conditions does trial NCT04707885 study?

This clinical trial studies the following conditions: Hearing Loss, Hearing Loss, Sensorineural, Hearing Loss, Bilateral.

What interventions are being tested in trial NCT04707885?

The interventions under investigation include: Electrocochleography (DEVICE).

Who is sponsoring clinical trial NCT04707885?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04707885 being conducted?

This trial has 5 study locations across Minnesota, Missouri, North Carolina, Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.